Navigation Links
AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Date:12/9/2008

REDWOOD CITY, Calif., Dec. 9 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. today announced positive results from a Phase 2 clinical study evaluating the safety and efficacy of its lead product candidate, ARX-01, for the treatment of moderate-to-severe inpatient acute pain following knee replacement surgery. The primary endpoint evaluated pain intensity (Sum of the Pain Intensity Difference - SPID12) over the 12-hour study period compared to baseline. Results demonstrated that compared to placebo, patients receiving 15 mcg of ARX-01 experienced a statistically significant reduction in pain intensity over the study period, based on the worst observation carried forward imputation method (WOCF), p=0.015. Additionally, at the 15 mcg dose, the study met an important secondary endpoint compared to placebo, the percentage of patient dropouts due to inadequate analgesia, p=0.006. Further, no serious or unexpected adverse events related to ARX-01 were reported in the study.

ARX-01 is a sublingual formulation of the opioid pain medication, sufentanil. ARX-01 is based on the company's proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.

"We chose a very painful surgery in an elderly patient population to showcase the efficacy and safety of Sublingual Sufentanil NanoTabs in treating acute post-operative pain," said Pamela Palmer, M.D., Ph.D., chief medical officer of AcelRx Pharmaceuticals. "The superior attributes of both the drug and the dosage form enabled these highly encouraging Phase 2 results."

This multicenter, double-blind, randomized, placebo-controlled, dose-finding Phase 2 study evaluated the safety and efficacy of ARX-01 in patients undergoing elective unilateral knee replacement surgery. In the study, 101 patients were randomized to receive either placebo or one of three different dosage strengths of ARX-01: 5mcg, 10m
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
...N ergoFET handheld digital force gauge (measures v...ers worldwide, is now more versatile and accurate....the force capacities have been doubled to accurate... Salt Lake City, Utah (PRWEB) March 18, 2009 -- ...Industries, Inc. , proudly announces engineering a...
... Cell Technologies, Inc. received the results toda...ted by renowned stem cell researcher and clinician...cal study of non-union bone injuries using autolog...ive traditional treatment therapies, indicated tha...ling capability in a shorter period of time with l...
...logies, Inc., a privately held provider of innovat...and disease research, today announced it will be s...olution this month and reviewed the company,s oppo...nnual Health Care Conference. , , The initial app...et-based technology platform focuses on targeted s...
Other Biology Technology:HOGGAN Ergo Announces Highly Anticipated Enhancements to the ergoFET Handheld Digital Force Gauge, Greatly Impacting the Field of Ergonomic Research and Application 2HOGGAN Ergo Announces Highly Anticipated Enhancements to the ergoFET Handheld Digital Force Gauge, Greatly Impacting the Field of Ergonomic Research and Application 3Renowned Stem Cell Researcher Files Study Results With Stemedica 2Renowned Stem Cell Researcher Files Study Results With Stemedica 3RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference 2RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference 3
(Date:12/2/2009)PHILADELPHIA Mexican-American adolescents exposed to cigarette smoking scenes in movies are more likely to pick up the habit themselves, and this may be part of the acculturation process associated w
(Date:12/2/2009)WEST LAFAYETTE, Ind. ╤ A Smoky Mountain forest,s woodland herb population has shown that climate may play a role in how forest understories recover from logging, according to Purdue University r
(Date:12/2/2009)HOBOKEN - A team comprised of undergraduate students from Stevens Institute of Technology was awarded top honors in a national poster contest hosted by the International Society for Pharmaceutical Eng
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Study finds logging effects vary based on a forest's history, climate 2Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 5173 1Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 5173 2Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 5173 3Pre Pregnancy Weight Linked to Babies Heart Problems 58714 1Pre Pregnancy Weight Linked to Babies Heart Problems 58714 2Veterans Give High Marks to VA Pharmacies 58710 1Veterans Give High Marks to VA Pharmacies 58710 2
...ologists at Rush University Medical Center implant...he eyes of five patients to treat vision loss caus...silicon microchip 2mm in diameter and one-thousand...human hair. , Four patients had surgery Tuesday, ...ater date. , Rush principal investigator Dr. John ...
...ghts by Duke University Medical Center researchers...offer a new approach for developing HIV vaccines. ...iled because they induce a class of antibodies tha...estroy. , The Duke team discovered that certain b...latch onto the HIV protein gp41, resemble antibodi...
...Africa, where days of heavy rains and flooding hav... wiped out, locals are reporting an unprecedented ...water surge may be headed into the centre of the c... to the UN Office for the Coordination of Humanita...Weyne, close to the border with Ethiopia, indicate...
Other Biology News:Ophthalmologists implant five patients with artificial silicon retina microchip 2Ophthalmologists implant five patients with artificial silicon retina microchip 3New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines 2New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines 3
Anti-Human I-FABP Polyclonal Antibody, Unconjugated from Cell Sciences
ProPrep BAC 960 from Biotech Support Group
ProPrep BAC 960 from Biotech Support Group
Chicken Anti-Plants Thaumatin 2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: